Monoclonal and bispecific antibodies as novel therapeutics.

Booy, Evan P; Johar, Dina; Maddika, Srilekha; Pirzada, Hasan; Sahib, Mickey M; Gehrke, Iris; Loewen, Shauna; Louis, Sherif F; Kadkhoda, Kamran; Mowat, Michael; Los, Marek

Booy, Evan P; Johar, Dina; Maddika, Srilekha; Pirzada, Hasan; Sahib, Mickey M; Gehrke, Iris; Loewen, Shauna; Louis, Sherif F; Kadkhoda, Kamran; Mowat, Michael; Los, Marek.

Affiliation

Booy EP; Manitoba Institute of Cell Biology,CancerCare Manitoba, University of Manitoba, ON6010-675 McDermot Ave., Winnipeg, MB, R3E 0V9, Canada.

Arch Immunol Ther Exp (Warsz) ; 54(2): 85-101, 2006.

Article in En | MEDLINE | ID: mdl-16648969

Subject(s)

Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Drug Design; Neoplasms/immunology; Antigens, Neoplasm/immunology; Humans; Neoplasms/therapy; Protein-Tyrosine Kinases/metabolism; Receptors, Growth Factor/antagonists & inhibitors; Receptors, Growth Factor/immunology; Receptors, Tumor Necrosis Factor/antagonists & inhibitors; Receptors, Tumor Necrosis Factor/immunology; Signal Transduction

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Drug Design / Antibodies, Bispecific / Antibodies, Monoclonal / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Arch Immunol Ther Exp (Warsz) Year: 2006 Type: Article Affiliation country: Canada

Search on Google

Add to My VHL

XML

PubMed Links